Conexeu Sciences holder reports 12.1% stake

Conexeu Sciences Inc. has a significant shareholder disclosure from Michael G. Wright on a Schedule 13G. Wright reports beneficial ownership of 3,276,643 common shares, representing 12.1% of the company’s common stock.

Rhea-AI Filing Summary

Conexeu Sciences Inc. has a significant shareholder disclosure from Michael G. Wright on a Schedule 13G. Wright reports beneficial ownership of 3,276,643 common shares, representing 12.1% of the company’s common stock. This ownership gives him sole voting and sole dispositive power over all reported shares.

The position includes 750,000 common shares held directly by Wright and 2,148,048 common shares held indirectly through N3GU Investments LLC, a Wyoming limited liability company over which he has sole voting and dispositive power. It also includes 50,000 shares underlying stock options, 78,595 shares underlying warrants, and 250,000 shares underlying performance warrants, each exercisable within 60 days of June 30, 2026. The 12.1% figure is based on 26,758,330 common shares outstanding as of June 10, 2026, plus the exercisable derivative securities held by Wright.

Key Figures

Beneficially owned shares: 3,276,643 shares Percent of class: 12.1% Shares outstanding baseline: 26,758,330 shares +5 more

8 metrics

Beneficially owned shares 3,276,643 shares Common stock beneficially owned by Michael G. Wright as reported on Schedule 13G

Percent of class 12.1% Portion of Conexeu Sciences common stock beneficially owned by Michael G. Wright

Shares outstanding baseline 26,758,330 shares Issued and outstanding common shares as of June 10, 2026

Directly held shares 750,000 shares Common shares held directly by Michael G. Wright

Indirect shares via N3GU 2,148,048 shares Common shares held indirectly through N3GU Investments LLC

Stock options exercisable in 60 days 50,000 shares Common shares underlying currently exercisable stock options

Warrants exercisable in 60 days 78,595 shares Common shares underlying currently exercisable warrants

Performance warrants exercisable in 60 days 250,000 shares Common shares underlying currently exercisable performance warrants

Key Terms

beneficially owned, Sole Voting Power, Sole Dispositive Power, performance warrants, +1 more

5 terms

beneficially owned financial

"Item 4. | Ownership (a) | Amount beneficially owned: 3,276,643.00"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Sole Voting Power financial

"5 | Sole Voting Power 3,276,643.00 6 | Shared Voting Power 0.00"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

Sole Dispositive Power financial

"7 | Sole Dispositive Power 3,276,643.00 8 | Shared Dispositive Power 0.00"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

performance warrants financial

"250,000 Common Shares underlying performance warrants that are currently exercisable"

Schedule 13G regulatory

"CONTEXT: form_type": "SCHEDULE 13G"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Conexeu Sciences Inc. (CNXU) shares does Michael G. Wright beneficially own?

Michael G. Wright reports beneficial ownership of 3,276,643 Conexeu Sciences common shares. This total includes directly held shares, shares held through N3GU Investments LLC, and shares underlying options and warrants exercisable within 60 days of June 30, 2026.

What percentage of Conexeu Sciences Inc. (CNXU) does Michael G. Wright own?

Michael G. Wright reports owning 12.1% of Conexeu Sciences’ common stock. This percentage is calculated using 26,758,330 shares outstanding as of June 10, 2026, plus the shares underlying his exercisable options and warrants.

How is Michael G. Wright’s Conexeu Sciences (CNXU) ownership structured between direct and indirect holdings?

His 3,276,643-share position includes 750,000 shares held directly and 2,148,048 shares held indirectly through N3GU Investments LLC, plus additional shares underlying stock options, warrants, and performance warrants exercisable within 60 days.

What derivative securities linked to Conexeu Sciences (CNXU) does Michael G. Wright hold?

Wright’s beneficial ownership includes 50,000 shares underlying stock options, 78,595 shares underlying warrants, and 250,000 shares underlying performance warrants, all exercisable within 60 days of June 30, 2026, in addition to his common shares.

Does Michael G. Wright have sole or shared voting power over his Conexeu Sciences (CNXU) shares?

He reports sole voting power over 3,276,643 shares and no shared voting power. He also has sole dispositive power over the same number of shares and no shared dispositive power.

What baseline share count is used to calculate Michael G. Wright’s 12.1% stake in Conexeu Sciences (CNXU)?

The 12.1% is based on 26,758,330 common shares issued and outstanding as of June 10, 2026, plus shares that would be outstanding upon exercise of Wright’s options, warrants, and performance warrants that are exercisable within 60 days.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/28/2026 - 01:11 PM Accepted by SEC EDGAR 07/28/2026 - 01:11 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Conexeu Sciences Inc.

(Name of Issuer)

Common Stock, no par value

(Title of Class of Securities)

20715F100

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 20715F100

1

Names of Reporting Persons

Wright Michael G.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

QUEBEC, CANADA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 3,276,643.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 3,276,643.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,276,643.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

12.1 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: (1) Rows 5, 7 and 9 include (i) 750,000 shares of common stock the Issuer ("Common Shares") held directly by Mr. Wright, (ii) 2,148,048 Common Shares held indirectly through N3GU Investments LLC, a Wyoming limited liability company ("N3GU"), which Mr. Wright has sole voting and sole dispositive power over, (iii) 50,000 Common Shares underlying stock options that are currently exercisable within 60 days of June 30, 2026 held directly by Mr. Wright, (iv) 78,595 Common Shares underlying warrants that are currently exercisable within 60 days of June 30, 2026 held indirectly by N3GU and (v) 250,000 Common Shares underlying performance warrants that are currently exercisable within 60 days of June 30, 2026 held indirectly by N3GU. (2) Row 11 is calculated based on (i) 26,758,330 issued and outstanding Common Shares as of June 10, 2026, as disclosed in the Issuer's Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission on June 15, 2026, plus (ii) the Common Shares that would be outstanding upon the exercise of stock options, warrants and performance warrants, directly and indirectly held by Mr. Wight, that are exercisable within 60 days of June 30, 2026.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Conexeu Sciences Inc.
(b)	Address of issuer's principal executive offices: 50 WEST LIBERTY STREET, SUITE 880, RENO, NEVADA, 89501.
Item 2.
(a)	Name of person filing: Michael G. Wright
(b)	Address or principal business office or, if none, residence: 18 Victor, Mille Isles, QC, Canada J0R 1A0
(c)	Citizenship: Canadian
(d)	Title of class of securities: Common Stock, no par value
(e)	CUSIP Number(s): 20715F100
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 3,276,643.00
(b)	Percent of class: 12.1%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 3,276,643.00
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 3,276,643.00
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.	Certifications:
	Not Applicable

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Wright Michael G.

Signature:	Michael G. Wright
Name/Title:	Michael G. Wright
Date:	07/28/2026